Sanity Group key facts
- Operator of a health and life science company intended to unlock the health benefits of cannabinoids.
- It has raised $130.6M; the latest was Later Stage VC ($15.1M) in Jun 2024.
- Notable investors include HV Capital, Cherry Ventures, TQ Ventures, Redalpine, Casa Verde Capital — 27 tracked in total.
- Status: Privately Held (backing).
Who backs Sanity Group
27+Membership and data by Private Market View
- ·The complete investor list: 27 names
- ·Watch Sanity Group: the Monday email on marks, rounds and moves
Sanity Group funding rounds
No funding rounds for Sanity Group are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Sanity Group investors
27 investors are on record for Sanity Group, including HV Capital, Cherry Ventures, TQ Ventures and Redalpine. By type, the record holds 5 venture capital firms and 2 hedge funds.
About Sanity Group
Operator of a health and life science company intended to unlock the health benefits of cannabinoids. The company is developing consumer products based on non-psychoactive cannabinoids, enabling pharmacies and clinical institutions to have access to medicinal cannabis products.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2018
- Employees
- 85
- Website
- sanitygroup.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Sanity Group doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.